Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 27, 2026
Hormel Foods (HRL) Drops -16.9% in 30 Days: Earnings and Consumer Pressures in Focus

Hormel Foods (HRL) Drops -16.9% in 30 Days: Earnings and Consumer Pressures in Focus

Key Takeaways

  • Hormel Foods (HRL) shares declined roughly 16.9% over the last 30 days, from $23.71 to $19.71.
  • Most of the move came on August 27, when the stock dropped about 10% following a mixed fiscal third-quarter report.
  • Adjusted EPS of $0.37 beat the $0.35 consensus estimate, but revenue of $2.96 billion missed and full-year net sales guidance was lowered.
  • Retail volume weakness and a strained consumer backdrop weighed on sentiment, while Foodservice posted its 12th straight quarter of organic sales growth.
  • Management raised and narrowed adjusted EPS guidance even as it trimmed its sales outlook, leaving investors focused on the top line.

A Quick Look at Hormel Foods and Its Market Position

Hormel Foods Corporation is a global branded food company headquartered in Austin, Minnesota, generating more than $12 billion in annual revenue. Its portfolio spans widely recognized brands including Planters, Skippy, SPAM, Jennie-O, Applegate, Hormel Natural Choice, Columbus, Wholly, and Hormel Black Label, sold through retail, foodservice, and international channels.

Investors follow the stock for its defensive consumer-staples profile, its diversified protein and snacking platform, and its reputation as a Dividend King, having raised its payout annually for more than 50 consecutive years. The company competes across packaged meats, nut butters, snack nuts, and value-added proteins, with its differentiated foodservice business a key strategic strength. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Performance: The Last 30 Days and Quarter

Over the last 30 days, HRL fell from $23.71 to $19.71, a decline of approximately 16.9%. The move was concentrated in a single session: on August 27, shares dropped more than 10% after quarterly results, and the stock continued to drift lower through September.

The quarterly trend has been even weaker. In late June, the stock traded near $26.50; by late September it had fallen to $19.71, a pullback of roughly 25%. The decline reflects a broader slide in the shares that has left HRL trading near the lower end of its 52-week range and underperforming the consumer-staples sector.

Key Drivers Behind the Recent Drop in HRL Shares

The dominant catalyst was Hormel's fiscal third-quarter earnings release on August 27. Adjusted earnings per share rose 6% year over year to $0.37, narrowly topping the $0.35 consensus. However, net sales of $2.96 billion missed the roughly $3.04 billion estimate, and organic net sales declined 2%, driven by portfolio-shaping actions, softer commodity-based pricing, and a pressured consumer environment.

Investors focused on the weaker top line. Retail net sales fell 4% with volume down 9%, while the International segment was weighed down by a non-cash impairment related to a minority investment in Indonesia and a one-time legal-entity transition affecting SPAM exports. Management also lowered its full-year net sales guidance to $12.1 billion to $12.2 billion from a prior range of $12.2 billion to $12.5 billion, even as it raised and narrowed adjusted EPS guidance to $1.45 to $1.51. Analysts responded cautiously; JPMorgan lowered its price target to $23 from $26 while maintaining a Neutral rating.

Leadership changes added to the news flow. John Ghingo was named CEO-elect and Ash Bhumbla was announced as incoming CFO, signaling a period of transition alongside the company's ongoing portfolio reshaping.

Broader Factors Influencing Performance Over the Quarter

The multi-month decline reflects a broader theme: a defensive food company navigating sluggish demand while repositioning its portfolio. Hormel has been exiting lower-margin businesses, including the Justin's brand divestiture, the planned sale of its Brazil (Ceratti) operations, and exits from whole-bird turkey and select private-label snack nuts. These actions weigh on reported sales even as they aim to sharpen focus on higher-margin branded growth.

At the same time, cumulative inflation and elevated fuel and freight costs have kept consumers value-focused, pressuring retail volumes. Foodservice has remained a bright spot with 12 consecutive quarters of organic growth, but it has not been enough to offset investor concerns about the retail business and the uncertain consumer backdrop. From what I see, this dynamic continues to shape sentiment.

Looking Ahead: Factors to Monitor for HRL

Looking ahead, investors will watch whether lower pork input costs translate into margin benefits as inventory turns, and whether elevated freight, fuel, and beef costs keep pressuring profitability. The timing and impact of the Brazil divestiture, along with the wrap-up of portfolio exits, will shape reported sales comparisons. Retail volume trends and consumer spending behavior remain central, as does the sustainability of Foodservice momentum.

The company's fourth-quarter results and any initial commentary on fiscal 2027 will be closely monitored, particularly around organic sales growth and the dividend's payout sustainability. Macroeconomic factors, including inflation, fuel prices, and consumer confidence, remain key swing variables. These are factors to monitor, not signals to buy or sell. I’m watching this closely as the next earnings cycle approaches.

Using Tickeron’s AI Trading Bots in My Analysis

In my regular research routine, I often review Tickeron’s AI Trading Bots to explore automated strategies that align with specific risk parameters and holding periods. This helps me cross-check sector trends and identify how different approaches might respond to names like HRL without replacing my own fundamental work. The platform’s selection of bots offers a practical way to see real-time performance across thousands of tickers, which I find useful when weighing both defensive and cyclical exposures.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HRL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


HRL in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 23, 2026

HRL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 22 of 38 cases where HRL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 58%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a +0.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where HRL advanced for three days, in 139 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for HRL turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 27 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HRL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

The Aroon Indicator for HRL entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.383) is normal, around the industry mean (5.349). P/E Ratio (31.790) is within average values for comparable stocks, (32.551). Projected Growth (PEG Ratio) (1.387) is also within normal values, averaging (8.458). Dividend Yield (0.059) settles around the average of (0.025) among similar stocks. P/S Ratio (0.942) is also within normal values, averaging (4.925).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. HRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HRL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Kraft Heinz Company (The) (NYSE:KHC), General Mills (NYSE:GIS), The Campbell's Company (NASDAQ:CPB), Beyond Meat Inc. (NASDAQ:BYND).

Industry description

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

Market Cap

The average market capitalization across the Food: Major Diversified Industry is 2.91B. The market cap for tickers in the group ranges from 68.81K to 239.66B. NSRGY holds the highest valuation in this group at 239.66B. The lowest valued company is THRC at 68.81K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Major Diversified Industry was -3%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was -11%. BGS experienced the highest price growth at 8%, while RKDA experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Food: Major Diversified Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 62
Price Growth Rating: 66
SMR Rating: 78
Profit Risk Rating: 93
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
HRL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of meat products and other prepared foods

Industry FoodMajorDiversified

Industry
Food Meat Or Fish Or Dairy
Address
1 Hormel Place
Phone
+1 507 437-5611
Employees
20000
Web
https://www.hormelfoods.com
Interact to see
Advertisement
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.